Skip to main content
. 2022 Mar 4;22:239. doi: 10.1186/s12885-022-09331-8

Fig. 6.

Fig. 6

Decision curve analysis (DCA) of the nomogram model. The model has a high net benefit and a wide range of threshold probabilities in predicting the risk of biochemical recurrence within five (A) and three years (B). “None” means that no individual receives treatment or intervention. “All” means that all patients are treated or intervened clinically. The DCA presents a reference for patients who make decisions according to their respective anticipations